LONDON (Thomson Financial) - Tepnel Life Sciences Plc., a Manchester-based
genetics specialist and service supplier, said AstraZeneca has extended an
agreement for Tepnel to supply it with DNA extraction services.
Tepnel will also have the opportunity to compete for further business with
AstraZeneca at volume-related discounts, the company said.
The company has supplied DNA services to AstraZeneca since May 2006.
julian.hofmann@thomsonreuters.com
jh1/hjp
COPYRIGHT
Copyright Thomson Financial News Limited 2008. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content,
including by framing or similar means, is expressly prohibited without the prior
written consent of Thomson Financial News.
|